Treatment of patients with lower urinary tract symptoms in Moscow
- Autores: Pushkar D.Y.1, Rasner P.I.1,2, Kotenko D.V1, Gerasimov A.N1, Shabalkin S.A1
-
Afiliações:
- A.I. Evdokimov Moscow State University of Medicine and Dentistry
- Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department
- Edição: Nº 3 (2019)
- Páginas: 7-12
- Seção: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/303628
- DOI: https://doi.org/10.18565/urology.2019.3.7-12
- ID: 303628
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Palavras-chave
Texto integral
Sobre autores
D. Pushkar
A.I. Evdokimov Moscow State University of Medicine and Dentistrycorresponding member of RAS, MD, professor, Head of the Department of Urology, Chief urologist of the Ministry of Health of Russia and Moscow
P. Rasner
A.I. Evdokimov Moscow State University of Medicine and Dentistry; Municipal clinical hospital named after S.I. Spasokukotskiy of the Moscow Healthcare Department
Email: dr.rasner@gmail.com
MD, professor at the Department of Urology; Head of the Department of Urology №4
D. Kotenko
A.I. Evdokimov Moscow State University of Medicine and DentistryPh.D., Department of Urology
A. Gerasimov
A.I. Evdokimov Moscow State University of Medicine and DentistryPh.D. in physical and mathematical sciences, professor, Head of the Department of Medical informatics and statistics
S. Shabalkin
A.I. Evdokimov Moscow State University of Medicine and DentistryDepartment of Urology
Bibliografia
- Nickel J.C., Downey J., Benard F. et al. The Canadian benign prostatic hyperplasia audit study (CanBas). Can. Urol. Assoc. J. 2008;2(4):367-373.
- Milsom I., Abrams P., Cardozo L., Roberts R.G., Thrnoff J.W., Wein A.J. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87:760.
- Hutchison A., Farmer R., Verhamme K., Berges R., Navarrete R.V., Reich O., de la Rosette JJMCH. The Efficacy of Drugs for the Treatment of LUTS/ BPH, A Study in 6 European Countries. Eur Urol 2007;51(Issue 1):207-216.
- Пушкарь Д.Ю., Раснер П.И., Котенко Д.В., Герасимов А.Н., Шабалкин С.А. Особенности симптомов нижних мочевыводящих путей у мужчин Московского региона. Результаты эпидемиологического исследования. Урология. 2018;3:20-28.
- Fourcade R.O., Lacoin F., Roupret M. et al. Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia. World J. Urol. 2012;30(3):419-426.
- Park J., Lee Y.J., Lee J.W. et al. Comparative analysis of benign prostatic hyperplasia management by urologists and nonurologists: a Korean nationwide health insurance database study. Korean J Urol. 2015;56(3):233-239.
- Cindolo L., Pirozzi L., Fanizza C., Romero M., Turbano A., Autorino R., De Nunzio C., Schips L. Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study. Eur Urol. 2015;68:418-427.
- Гаджиева З.К., Казилов Ю.Б., Аляев Ю.К., Абоян И.А., Казилов Б.Р. Нарушения мочеиспускания. Все ли мы о них знаем? Урология. 2014;1:20-26.
- Helfand B.T., Evans R.M., McVary K.T. et al. Medical treatment of LUTS/ BPH: analysis of 8,7 million American men. J Urol. 2009;181(4):647.
- Шпиленя Е.С. Доброкачественная гиперплазия предстательной железы: современное видение проблемы. Эффективная фармакотерапия. 2018;2:42-45.
- Verhamme K.M.C., Dieleman J.P., Bleumink G.S., J van der Lei, Sturken-boom M.C.J.M. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care: the TRIUMPH project. Eur Urol. 2002;42:323-328.
- Nichol M.B., Knight T.K., Wu J., Barron R., Penson D.F. Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia. J Urol. 2009;181(22):14-21.